Sunil Healthcare Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 314.75 million compared to INR 225.1 million a year ago. Revenue was INR 316.29 million compared to INR 261.1 million a year ago. Net income was INR 21.62 million compared to INR 0.194 million a year ago. Basic earnings per share from continuing operations was INR 2.11 compared to INR 0.02 a year ago. Diluted earnings per share from continuing operations was INR 2.11 compared to INR 0.02 a year ago.
For the nine months, sales was INR 871.69 million compared to INR 669.94 million a year ago. Revenue was INR 879.94 million compared to INR 713.85 million a year ago. Net income was INR 24.1 million compared to net loss of INR 0.403 million a year ago. Basic earnings per share from continuing operations was INR 2.35 compared to basic loss per share from continuing operations of INR 0.04 a year ago. Diluted earnings per share from continuing operations was INR 2.35 compared to diluted loss per share from continuing operations of INR 0.04 a year ago.